Maximum quantity allowed is 999
Please select the quantity
CAS RN: 17388-39-5 | Product Number: S0897
Swertiamarin
Purity: >98.0%(HPLC)
Synonyms:
Product Documents:
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Shipping Information |
---|---|---|---|---|---|
25MG |
NT$6,520
|
0 | 0 | Contact Us |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Product Number | S0897 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__1__6H__2__2O__1__0 = 374.34 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
Packaging and Container | 25MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 17388-39-5 |
Reaxys Registry Number | 55278 |
PubChem Substance ID | 172088922 |
Merck Index (14) | 9010 |
MDL Number | MFCD07783984 |
Specifications
Appearance | White to Yellow to Orange powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Specific rotation [a]20/D | -136 to -141 deg(C=0.5、EtOH) |
NMR | confirm to structure |
Properties (reference)
Melting Point | 114 °C |
Specific Rotation | -138° (C=0.5,EtOH) |
Maximum Absorption Wavelength | 238(MeOH) nm |
GHS
Related Laws:
RTECS# | UQ1366700 |
Transport Information:
H.S.code* | 2938.90-000 |
Application
Swertiamarin: The Bitter Component of the Herb of Swertia japonica
Swertiamarin, a secoiridoid glycoside, is the bitter component of the herb of Swertia japonica.1) The main biosynthetic pathway of swertiamarin in the Gentianae is a route which leads from iridodial via deoxyloganic acid or loganic acid to secoiridoids.2) It has been reported that swertiamarin has diverse biological activities, including anti-inflammatory,3) anti-hyperlipidaemic,3) anti-nociceptive,4) hepatoprotective,4) anti-diabetic5-7) and antioxidant7) effects. (The product is for research purpose only)
References
- 1) Systematic review on xanthones and others isolates from genus Swertia
- A. Jamwal, Int. J. Pharm. Chem. Sci. 2012, 1, 1115.
- 2) Chemotaxonomy and pharmacology of Gentianaceae
- S. R. Jensen, J. Schripsema, in Gentianaceae: Systematics and Natural History, eds. by L. Struwe, V. A. Albert, Cambridge University Press, Cambridge, 2002, pp. 573-631.
- 3) Naturally occurring iridoids, secoiridoids and their bioactivity. An updated review, part 3
- 4) Naturally occurring iridoids, secoiridoids. An updated review, part 4
- 5) Decrease in serum matrix metalloproteinase-9 and matrix metalloproteinase-3 levels in Zucker fa/fa obese rats after treatment with swertiamarin
- 6) Glycogen phosphorylase-a is a common target for anti-diabetic effect of iridoid and secoiridoid glycosides
- 7) A systematic review of the protective role of swertiamarin in cardiac and metabolic diseases
PubMed Literature
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.